Does ENASIDENIB Cause Intentional product use issue? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Intentional product use issue have been filed in association with ENASIDENIB (Idhifa). This represents 0.3% of all adverse event reports for ENASIDENIB.
11
Reports of Intentional product use issue with ENASIDENIB
0.3%
of all ENASIDENIB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Intentional product use issue From ENASIDENIB?
Of the 11 reports, 2 (18.2%) resulted in death, 6 (54.5%) required hospitalization.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Off label use (213)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Decreased appetite (122)
Platelet count decreased (113)
Drug ineffective (108)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which ENASIDENIB Alternatives Have Lower Intentional product use issue Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ